Chlovalicin, a new cytocidal antibiotic produced by Sporothrix sp. FO-4649. II. Physicochemical properties and structural elucidation

Journal of Antibiotics

Volumn 49, Issue 7, 1996, Pages 635-638

  Takamatsu, Satoshi ^a   Kim, Yong Pil ^a   Komiya, Takamaro ^a   Sunazuka, Toshiaki ^a   Hayashi, Masahiko ^a   Tanaka, Haruo ^a   Komiyama, Kanki ^a   Omura, Satoshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOVALICIN; OVALICIN; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; HYPHOMYCETES; MASS SPECTROMETRY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

EID: 0029761558     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.635     Document Type: Article

References (16)

1. YAMASAKI, K.; T. TAGA, Y. HIRATA, H. YAWATA, Y. KAWANISHI, B. SEED, T. TANIGUCHI, T. HIRANO & T. KISHIMOTO: Cloning and expression of the human interleukin-6 (BSF-2/IFNb) receptor. Science 241: 825-828, 1988
2. STRASSMANN, G.; M. FOMG, J. S. KENNEY & C. O. JACOB: Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89: 1681-1684, 1992
3. STRASSMANN, G.; Y. MASUI, R. CHIZZONITE & M. FONG: Mechanisms of experimental cancer cachexia. J. Immunology 150: 2341-2345, 1993
4. SODA, K.; M. KAWAKAMI, A. KASHII & M. MIYATA: Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin-6 as the sole inducer of cachexia. Jpn. J. Cancer Res. 85: 1124-1130, 1994
5. YASUMOTO, K.; N. MUKAIDA, A. HARADA, K. KUNO, M. AKIYAMA, E. NAKASHIMA, N. FUJIOKA, M. MAI, T. KASAHARA, K. FUJIMOTO-OUCHI, K. MORI, Y. TANAKA & K. MATSUSHIMA: Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice. Cancer Research 55: 921-927, 1995
6. HAYASHI, M.; Y.-P. KIM, S. TAKAMATSU, T. KOMIYA, R. MASUMA, S. PREEPRAME, K. KOMIYAMA, H. TANAKA & S. ŌMURA: Chlovalicin, a new cytocidal antibiotic produced by Sporothrix sp. FO-4649. I. Taxonomy, fermentation, isolation and biological activities. J. Antibiotics 49: 631-634, 1996
7. AIZAWA, S.; H. AKATSU, T. SATOMI, S. KAWABATA & K. SASAKI: AA-57, A new antibiotic related to pentalenolactone. J. Antibiotics 31: 729-731, 1978
8. BOLLINGER, P.; H.-P. STIGG & H.-P. WEBER: Die Struktur von ovalicin. Helv. Chim. Acta 56: 819-830, 1973
9. STEWART, C. A. & C. A. VANDERWERF: Reaction of propylene oxide with hydrogen halides. J. Am. Chem. Soc. 76: 1259-1264, 1954
10. STIGG, H. P. & H. P. WEBER: 156. Isolierung und strukturaufklarung von ovalicin. Helv. Chim. Acta 51: 1395-1408, 1968
11. SASSA, T.; H. KAISE, Y. OGAWA & K. MUNAKATA: Isolation of new lettuce seed germination stimulant. Nature 222: 773-774, 1969
12. SASSA, T.; H. KAISE & K. MUNAKATA: The structure of graphinone. Agr. Biol. Chem. 34: 649-651, 1970
13. HARTMANN, G. R.; H. RICHTER, E. M. WEINER & W. ZIMMERMANN: On the mechanism of action of the cytostatic drug anguidine and of the immunosuppressive agent ovalicin, two sesquiterpene from fungi. Planta Medica 34: 231-252, 1978
14. CANE, D. E. & R. H. LEVIN: Application of carbon-13 magnetic resonance to isoprenoid biosynthesis. I. Ovalicin. J. Am. Chem. Soc. 97: 1282-1285, 1975
15. 13C-acetate into the fungal sesquiterpene ovalicin. Tetrahedron Lett. 4417-4420, 1974
16. COREY, E. J. & J. P. DITTAMI: Total synthesis of (±)-ovalicin. J. Am. Chem. Soc. 107: 256-257, 1985